Open AccessThe Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer
Author(s) -
Faris Abushamma,
Zain Khayyat,
Aya Soroghle,
Sa’ed H. Zyoud,
Ahmad Jaradat,
Maha Akkawi,
Hanood Abu-Rass,
Iyad K. K. Qaddumi,
Razan Odeh,
Husam Salameh,
Salah Al-Buheissi
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s299148
Subject(s) - medicine , bladder cancer , cystoscopy , retrospective cohort study , cohort , observational study , cancer , cohort study , propensity score matching , oncology , urology , surgery , urinary system
Non-muscle invasive bladder cancer (NMIBC) is a potentially curable or controllable disease if strict adherence to a surveillance protocol is followed. Management and surveillance of NMIBC begins at the time of diagnosis up to a few years thereafter. There is scanty data in the literature evaluating the impact of non-compliance with the surveillance protocols on progression, recurrence, and mortality rate.